Lee N - Search Results

1

Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.

Nielsen S, Dietze P, Lee N, Dunlop A, Taylor D. Nielsen S, et al. Among authors: lee n. Addiction. 2007 Apr;102(4):616-22. doi: 10.1111/j.1360-0443.2006.01731.x. Epub 2007 Feb 6. Addiction. 2007. PMID: 17286641

2

Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identified.

Nielsen S, Dietze P, Dunlop A, Muhleisen P, Lee N, Taylor D. Nielsen S, et al. Among authors: lee n. Drug Alcohol Rev. 2007 Mar;26(2):143-51. doi: 10.1080/09595230601146645. Drug Alcohol Rev. 2007. PMID: 17364849

3

Methadone- and buprenorphine-related ambulance attendances: a population-based indicator of adverse events.

Nielsen S, Dietze P, Cantwell K, Lee N, Taylor D. Nielsen S, et al. Among authors: lee n. J Subst Abuse Treat. 2008 Dec;35(4):457-61. doi: 10.1016/j.jsat.2007.12.007. Epub 2008 Mar 4. J Subst Abuse Treat. 2008. PMID: 18295435

4

Characteristics of a nontreatment-seeking sample of over-the-counter codeine users: implications for intervention and prevention.

Nielsen S, Cameron J, Lee N. Nielsen S, et al. Among authors: lee n. J Opioid Manag. 2011 Sep-Oct;7(5):363-70. J Opioid Manag. 2011. PMID: 22165035

5

Protocol for a systematic review of psychological treatment for methamphetamine use: an analysis of methamphetamine use and mental health symptom outcomes.

Stuart A, Baker AL, Bowman J, McCarter K, Denham AMJ, Lee N, Colyvas K, Dunlop A. Stuart A, et al. Among authors: lee n. BMJ Open. 2017 Sep 7;7(9):e015383. doi: 10.1136/bmjopen-2016-015383. BMJ Open. 2017. PMID: 28882907 Free PMC article.

6

Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.

McKetin R, Ross J, Kelly E, Baker A, Lee N, Lubman DI, Mattick R. McKetin R, et al. Among authors: lee n. Drug Alcohol Rev. 2008 May;27(3):277-85. doi: 10.1080/09595230801919486. Drug Alcohol Rev. 2008. PMID: 18368609

7

Differences in self and independent ratings on an organisational dual diagnosis capacity measure.

Lee N, Cameron J. Lee N, et al. Drug Alcohol Rev. 2009 Nov;28(6):682-4. doi: 10.1111/j.1465-3362.2009.00116.x. Drug Alcohol Rev. 2009. PMID: 19930024

8

The influence of depression on treatment for methamphetamine use.

Kay-Lambkin FJ, Baker AL, Lee NM, Jenner L, Lewin TJ. Kay-Lambkin FJ, et al. Med J Aust. 2011 Aug 1;195(3):S38-43. doi: 10.5694/j.1326-5377.2011.tb03264.x. Med J Aust. 2011. PMID: 21806517 Clinical Trial.

9

Stepping through treatment: reflections on an adaptive treatment strategy among methamphetamine users with depression.

Kay-Lambkin FJ, Baker AL, McKetin R, Lee N. Kay-Lambkin FJ, et al. Among authors: lee n. Drug Alcohol Rev. 2010 Sep;29(5):475-82. doi: 10.1111/j.1465-3362.2010.00203.x. Drug Alcohol Rev. 2010. PMID: 20887570

10

A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: feasibility, tolerability and clinical outcomes.

Lee N, Pennay A, Hester R, McKetin R, Nielsen S, Ferris J. Lee N, et al. Drug Alcohol Rev. 2013 Jan;32(1):88-95. doi: 10.1111/j.1465-3362.2012.00473.x. Epub 2012 May 27. Drug Alcohol Rev. 2013. PMID: 22630616 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,636 results

Search Page

Filters